Neogen (NEOG) Financials

$5.62 -0.13 (-2.19%)

As of 11:28 AM Eastern

Annual Income Statements for Neogen

This table shows Neogen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	5/31/2014	5/31/2015	5/31/2016	5/31/2017	5/31/2018	5/31/2019	5/31/2020	5/31/2021	5/31/2022	5/31/2023	5/31/2024
Net Income / (Loss) Attributable to Common Shareholders	28	34	37	44	63	60	59	61	48	-23	-9.42
Consolidated Net Income / (Loss)	28	34	37	44	63	60	59	61	48	-23	-9.42
Net Income / (Loss) Continuing Operations	28	34	37	44	63	60	59	61	48	-23	-9.42
Total Pre-Tax Income	43	52	56	67	73	73	72	75	60	-22	-14
Total Operating Income	43	53	56	65	70	68	68	74	59	38	59
Total Gross Profit	123	140	153	169	186	192	196	215	243	406	464
Total Revenue	247	283	321	358	398	414	418	468	527	822	924
Operating Revenue	247	283	321	358	398	414	418	468	527	822	924
Total Cost of Revenue	125	143	168	189	212	222	222	253	284	416	460
Operating Cost of Revenue	125	143	168	189	212	222	222	253	284	416	460
Total Operating Expenses	79	87	97	104	116	124	129	141	184	368	405
Selling, General & Admin Expense	24	25	29	34	38	41	44	51	83	201	200
Marketing Expense	46	52	58	59	67	70	70	73	85	141	183
Research & Development Expense	8.33	9.58	9.89	10	11	13	15	16	17	26	22
Total Other Income / (Expense), net	-0.36	-1.04	-0.87	1.73	3.27	4.87	4.78	1.10	1.59	-60	-73
Interest Expense	-	-	-	-	-	-	-	0.08	0.07	56	73
Interest & Investment Income	0.35	0.38	0.54	1.01	2.19	4.83	5.99	1.69	1.34	3.17	6.36
Other Income / (Expense), net	-0.71	-1.42	-1.41	0.72	1.08	0.03	-1.21	-0.52	0.32	-6.76	-5.94
Income Tax Expense	15	19	19	23	10	13	13	14	12	0.83	-4.88
Basic Earnings per Share	$0.77	$0.91	$0.73	$0.87	$1.23	$0.58	$0.57	$0.57	$0.45	($0.12)	($0.04)
Weighted Average Basic Shares Outstanding	36.51M	36.95M	37.40M	50.54M	51.36M	103.78M	105.10M	106.50M	107.68M	188.88M	216.48M
Diluted Earnings per Share	$0.76	$0.90	$0.72	$0.86	$1.21	$0.57	$0.56	$0.57	$0.45	($0.12)	($0.04)
Weighted Average Diluted Shares Outstanding	36.51M	36.95M	37.40M	50.54M	52.15M	104.85M	105.72M	107.12M	108.02M	188.88M	216.48M
Weighted Average Basic & Diluted Shares Outstanding	36.51M	36.95M	37.40M	50.54M	51.36M	51.89M	52.96M	107.48M	107.84M	216.31M	216.69M

This table shows Neogen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q2 2025	Q3 2025
Period end date	5/31/2022	8/31/2022	11/30/2022	2/28/2023	5/31/2023	8/31/2024	11/30/2023	2/29/2024	5/31/2024	11/30/2024	2/28/2025
Net Income / (Loss) Attributable to Common Shareholders	15	5.21	-42	8.19	5.57	-13	-3.49	-2.02	-5.42	-456	-11
Consolidated Net Income / (Loss)	15	5.21	-42	8.19	5.57	-13	-3.49	-2.02	-5.42	-456	-11
Net Income / (Loss) Continuing Operations	15	5.21	-42	8.19	5.57	-13	-3.49	-2.02	-5.42	-456	-11
Total Pre-Tax Income	19	6.66	-34	-2.26	7.65	-16	-3.75	-5.82	-6.40	-477	-9.73
Total Operating Income	18	6.06	-7.66	16	23	2.26	14	12	13	-457	5.42
Total Gross Profit	65	62	113	108	123	105	117	117	113	113	110
Total Revenue	140	132	230	218	242	217	230	229	237	231	221
Operating Revenue	140	132	230	218	242	217	230	229	237	231	221
Total Cost of Revenue	75	70	117	110	119	112	113	112	123	118	111
Operating Cost of Revenue	75	70	117	110	119	112	113	112	123	118	111
Total Operating Expenses	47	56	120	92	100	103	102	105	100	571	105
Selling, General & Admin Expense	22	28	77	46	50	52	52	52	51	58	56
Marketing Expense	21	23	36	39	43	46	45	48	44	47	45
Research & Development Expense	3.83	4.88	6.85	7.26	7.05	5.20	5.76	4.85	5.15	5.11	4.47
Impairment Charge	-	-	-	-	-	-	0.00	-	-	461	0.00
Total Other Income / (Expense), net	0.88	0.60	-26	-18	-16	-18	-18	-18	-19	-19	-15
Interest Expense	-	0.00	21	17	18	19	18	18	19	18	18
Interest & Investment Income	0.54	0.97	0.55	0.64	1.00	0.99	1.86	1.61	1.10	0.77	0.70
Other Income / (Expense), net	0.36	-0.37	-6.44	-1.12	1.18	-0.24	-2.04	-1.17	-1.92	-1.72	1.90
Income Tax Expense	3.95	1.45	7.75	-10	2.08	-3.00	-0.26	-3.80	-0.98	-20	1.23
Basic Earnings per Share	$0.14	$0.05	($0.19)	$0.04	$0.03	($0.06)	($0.02)	($0.01)	($0.02)	($2.10)	($0.05)
Weighted Average Basic Shares Outstanding	107.68M	107.84M	216.13M	216.22M	188.88M	216.70M	216.41M	216.60M	216.48M	216.81M	217.03M
Diluted Earnings per Share	$0.14	$0.05	($0.19)	$0.04	$0.03	($0.06)	($0.02)	($0.01)	($0.02)	($2.10)	($0.05)
Weighted Average Diluted Shares Outstanding	108.02M	107.86M	216.13M	216.40M	188.88M	216.70M	216.41M	216.60M	216.48M	216.81M	217.03M
Weighted Average Basic & Diluted Shares Outstanding	107.84M	107.84M	216.15M	216.22M	216.31M	216.70M	216.52M	216.61M	216.69M	216.94M	217.04M

This table details how cash moves in and out of Neogen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	5/31/2014	5/31/2015	5/31/2016	5/31/2017	5/31/2018	5/31/2019	5/31/2020	5/31/2021	5/31/2022	5/31/2023	5/31/2024
Net Change in Cash & Equivalents	-9.36	25	-11	22	5.51	-41	25	9.33	-31	119	7.37
Net Cash From Operating Activities	22	44	35	60	69	64	86	81	68	41	35
Net Cash From Continuing Operating Activities	22	44	35	60	69	64	86	81	68	41	35
Net Income / (Loss) Continuing Operations	28	34	37	44	63	60	59	61	48	-23	-9.42
Consolidated Net Income / (Loss)	28	34	37	44	63	60	59	61	48	-23	-9.42
Depreciation Expense	9.18	11	12	15	17	18	18	21	24	88	117
Amortization Expense	-	-	-	-	-	-	-	0.00	0.44	4.82	7.95
Non-Cash Adjustments To Reconcile Net Income	-1.07	1.98	2.52	1.34	4.91	5.54	6.47	6.44	0.02	14	20
Changes in Operating Assets and Liabilities, net	-14	-2.41	-16	0.27	-16	-20	1.54	-7.27	-4.42	-43	-100
Net Cash From Investing Activities	-51	-28	-61	-62	-83	-119	-89	-106	-97	201	-29
Net Cash From Continuing Investing Activities	-51	-28	-61	-62	-83	-119	-89	-106	-97	201	-29
Purchase of Property, Plant & Equipment	-12	-9.62	-14	-15	-21	-15	-24	-27	-24	-66	-111
Acquisitions	-39	-6.55	-42	-34	-0.47	-6.39	-13	-51	-39	12	0.00
Purchase of Investments	-92	-106	-152	-163	-361	-437	-458	-793	-416	-13	0.00
Sale of Property, Plant & Equipment	-	-	-	-	-	-	-	0.00	0.00	0.83	0.11
Sale and/or Maturity of Investments	91	94	147	149	300	339	407	765	382	267	82
Net Cash From Financing Activities	20	11	15	25	23	14	29	34	6.81	-118	1.92
Net Cash From Continuing Financing Activities	20	11	15	25	23	14	29	34	6.81	-118	1.92
Repayment of Debt	-	-	-	-	-	-	-	0.00	0.00	-119	-0.54
Issuance of Common Equity	-	-	-	21	23	17	29	35	7.93	1.20	2.46
Other Financing Activities, net	20	11	15	3.92	-0.42	0.00	0.00	-1.09	-1.12	0.00	0.00
Effect of Exchange Rate Changes	0.66	-0.98	-0.29	-0.90	-3.38	0.02	-1.92	0.26	-8.75	-	-0.50
Cash Interest Paid	-	-	-	-	-	-	-	0.08	0.07	43	73
Cash Income Taxes Paid	9.96	10	13	18	15	13	7.36	15	17	15	22

This table details how cash moves in and out of Neogen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q3 2025
Period end date	2/28/2022	5/31/2022	8/31/2022	11/30/2022	2/28/2023	5/31/2023	8/31/2024	11/30/2023	2/29/2024	5/31/2024	2/28/2025
Net Change in Cash & Equivalents	-8.24	1.59	68	-13	-30	93	-50	27	-44	9.17	-13
Net Cash From Operating Activities	6.59	20	-14	-19	-17	91	-18	16	-30	27	19
Net Cash From Continuing Operating Activities	6.59	20	-14	-19	-17	91	-18	16	-30	27	19
Net Income / (Loss) Continuing Operations	5.44	15	5.21	-42	8.19	5.57	-13	-3.49	-2.02	-5.42	-11
Consolidated Net Income / (Loss)	5.44	15	5.21	-42	8.19	5.57	-13	-3.49	-2.02	-5.42	-11
Depreciation Expense	6.32	5.86	5.73	27	27	28	30	29	30	29	29
Amortization Expense	-	0.44	0.00	1.00	0.86	2.96	0.86	0.86	0.86	5.37	0.86
Non-Cash Adjustments To Reconcile Net Income	1.70	-5.03	1.87	2.18	6.61	3.48	3.80	4.27	3.69	9.64	6.18
Changes in Operating Assets and Liabilities, net	-6.87	4.16	-27	-6.80	-60	51	-40	-15	-62	-12	-6.09
Net Cash From Investing Activities	-15	-17	82	93	20	6.88	-34	12	-15	-18	-32
Net Cash From Continuing Investing Activities	-15	-17	82	93	20	6.88	-34	12	-15	-18	-32
Purchase of Property, Plant & Equipment	-6.66	-13	-13	-12	-15	-26	-38	-24	-32	-24	-33
Sale of Property, Plant & Equipment	-	-	0.00	0.61	0.08	0.14	4.45	0.03	-0.01	0.05	0.42
Net Cash From Financing Activities	1.22	-1.03	0.91	-79	-40	0.25	0.98	-0.31	1.25	-0.08	0.95
Net Cash From Continuing Financing Activities	1.22	-1.03	0.91	-79	-40	0.25	0.98	-0.31	1.25	-0.08	0.95
Issuance of Common Equity	1.22	0.09	0.91	0.02	0.02	0.25	1.08	0.17	1.30	0.01	1.06
Other Financing Activities, net	-	-	-	-	-	-	-	-	-	-	-0.12
Effect of Exchange Rate Changes	-0.67	-0.67	-	-	-	-	-	-	-	-	-0.39

This table presents Neogen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	5/31/2014	5/31/2015	5/31/2016	5/31/2017	5/31/2018	5/31/2019	5/31/2020	5/31/2021	5/31/2022	5/31/2023	5/31/2024
Total Assets	345	392	450	528	618	696	797	920	993	4,554	4,549
Total Current Assets	189	231	248	293	376	450	537	591	627	586	589
Cash & Equivalents	41	66	55	78	83	42	66	76	44	163	171
Short-Term Investments	36	48	53	66	128	226	277	305	337	82	0.33
Accounts Receivable	52	59	68	69	79	83	85	92	100	153	173
Inventories, net	51	52	64	73	76	86	95	101	122	134	189
Prepaid Expenses	7.46	4.23	8.41	7.61	9.89	13	14	18	24	53	56
Plant, Property, & Equipment, net	42	44	55	62	73	75	79	100	111	199	277
Total Noncurrent Assets	115	117	147	174	169	171	181	228	256	3,770	3,682
Goodwill	68	70	89	105	100	104	110	131	143	2,137	2,136
Intangible Assets	46	46	59	69	15	16	67	92	108	1,605	1,512
Other Noncurrent Operating Assets	-	-	-	-	55	52	4.18	4.50	5.34	27	35
Total Liabilities & Shareholders' Equity	345	392	450	528	618	696	797	920	993	4,554	4,549
Total Liabilities	39	41	46	57	58	58	72	80	106	1,420	1,405
Total Current Liabilities	25	25	29	36	39	38	48	54	78	145	154
Accounts Payable	13	14	16	16	21	19	26	24	35	77	83
Current Deferred Revenue	-	-	-	-	-	-	-	3.40	5.46	4.62	4.63
Current Deferred & Payable Income Tax Liabilities	0.00	1.28	0.00	0.94	0.17	0.60	1.46	1.85	2.13	6.95	10
Current Employee Benefit Liabilities	4.36	4.14	4.99	5.00	6.07	7.09	7.74	11	11	25	20
Other Current Liabilities	-	-	-	-	-	-	-	-	-	21	25
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	0.00	11	11
Total Noncurrent Liabilities	14	16	17	21	19	20	24	26	28	1,275	1,250
Long-Term Debt	1.88	2.05	-	-	-	-	-	-	0.00	885	888
Noncurrent Deferred & Payable Income Tax Liabilities	12	14	15	17	14	16	18	22	17	353	327
Other Noncurrent Operating Liabilities	-	-	2.42	3.60	5.04	3.97	5.39	4.30	11	36	35
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	306	351	404	472	560	638	725	840	887	3,134	3,144
Total Preferred & Common Equity	306	351	404	472	560	638	725	840	887	3,134	3,144
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	306	351	404	472	560	638	725	840	887	3,134	3,144
Common Stock	124	138	156	183	211	230	266	312	327	2,602	2,619
Retained Earnings	182	216	252	296	359	419	479	540	588	565	556
Accumulated Other Comprehensive Income / (Loss)	0.37	-2.44	-3.95	-7.20	-9.75	-12	-20	-11	-28	-33	-30

This table presents Neogen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q2 2025	Q3 2025
Period end date	2/28/2022	8/31/2022	11/30/2022	2/28/2023	8/31/2024	11/30/2023	2/29/2024	11/30/2024	2/28/2025
Total Assets	981	977	4,563	4,509	4,503	4,602	4,582	4,054	4,036
Total Current Assets	610	608	643	555	541	624	602	570	552
Cash & Equivalents	43	107	100	67	120	206	161	140	128
Short-Term Investments	336	241	176	116	0.00	25	7.01	0.00	0.00
Accounts Receivable	93	93	143	146	168	150	174	164	160
Inventories, net	113	129	136	144	199	161	182	198	205
Prepaid Expenses	25	38	88	82	54	83	78	68	58
Plant, Property, & Equipment, net	105	121	148	165	301	244	272	311	328
Total Noncurrent Assets	267	246	3,772	3,789	3,662	3,734	3,708	3,173	3,157
Goodwill	150	140	2,122	2,135	2,137	2,138	2,136	1,673	1,672
Intangible Assets	112	15	1,642	1,634	1,490	1,565	1,540	1,463	1,439
Other Noncurrent Operating Assets	4.78	91	7.61	19	34	31	32	37	46
Total Liabilities & Shareholders' Equity	981	977	4,563	4,509	4,503	4,602	4,582	4,054	4,036
Total Liabilities	106	94	1,457	1,383	1,368	1,455	1,436	1,385	1,376
Total Current Liabilities	66	67	153	107	123	177	158	151	141
Accounts Payable	24	27	79	60	61	112	90	80	72
Current Deferred Revenue	-	5.46	5.08	6.77	5.64	4.68	5.49	5.65	5.77
Current Deferred & Payable Income Tax Liabilities	0.00	3.92	9.05	1.65	11	10	12	11	13
Current Employee Benefit Liabilities	9.66	8.30	15	17	16	16	20	16	18
Other Current Liabilities	-	-	-	-	25	-	2.52	25	28
Other Current Nonoperating Liabilities	-	-	14	3.44	3.55	11	3.44	11	3.44
Total Noncurrent Liabilities	40	27	1,304	1,276	1,245	1,278	1,278	1,234	1,235
Long-Term Debt	-	-	924	885	889	887	888	890	891
Noncurrent Deferred & Payable Income Tax Liabilities	21	16	364	363	318	355	354	302	301
Other Noncurrent Operating Liabilities	19	11	16	29	39	36	37	42	43
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	876	884	3,106	3,126	3,135	3,148	3,146	2,669	2,660
Total Preferred & Common Equity	876	884	3,106	3,126	3,135	3,148	3,146	2,669	2,660
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	876	884	3,106	3,126	3,135	3,148	3,146	2,669	2,660
Common Stock	325	330	2,595	2,599	2,624	2,610	2,615	2,627	2,632
Retained Earnings	573	593	551	559	543	563	561	87	76
Accumulated Other Comprehensive Income / (Loss)	-22	-39	-40	-33	-31	-25	-29	-45	-48

This table displays calculated financial ratios and metrics derived from Neogen's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	5/31/2014	5/31/2015	5/31/2016	5/31/2017	5/31/2018	5/31/2019	5/31/2020	5/31/2021	5/31/2022	5/31/2023	5/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.22%	14.42%	13.50%	11.52%	11.07%	4.09%	0.96%	12.03%	12.53%	56.02%	12.37%
EBITDA Growth	7.95%	20.21%	7.71%	19.66%	9.93%	-2.92%	-1.21%	11.79%	-12.27%	49.20%	43.12%
EBIT Growth	5.05%	21.12%	6.34%	19.45%	8.55%	-4.42%	-2.66%	11.07%	-19.98%	-47.82%	71.45%
NOPAT Growth	5.65%	21.16%	8.36%	15.41%	41.01%	-7.01%	-1.11%	8.01%	-21.60%	-44.16%	56.37%
Net Income Growth	3.66%	19.78%	8.82%	20.35%	43.76%	-4.81%	-1.16%	2.37%	-20.65%	-147.34%	58.81%
EPS Growth	1.33%	18.42%	8.82%	20.35%	40.70%	-4.81%	-1.16%	2.37%	-21.05%	-126.67%	66.67%
Operating Cash Flow Growth	-18.42%	102.10%	-19.32%	70.60%	14.69%	-7.65%	34.52%	-5.58%	-16.09%	-39.70%	-14.05%
Free Cash Flow Firm Growth	-699.58%	195.37%	-175.34%	154.29%	253.52%	-9.87%	25.45%	-140.19%	99.99%	-349,034,399.41%	98.58%
Invested Capital Growth	32.37%	3.09%	24.08%	10.72%	6.47%	5.97%	3.04%	20.39%	10.24%	647.59%	2.31%
Revenue Q/Q Growth	4.77%	4.18%	3.70%	1.54%	3.27%	0.40%	-0.16%	4.08%	2.46%	14.11%	-0.54%
EBITDA Q/Q Growth	3.11%	5.86%	2.15%	5.69%	0.89%	-0.98%	2.26%	1.74%	-1.60%	33.81%	-5.66%
EBIT Q/Q Growth	2.80%	6.58%	1.58%	5.94%	0.57%	-1.55%	2.49%	0.73%	-2.84%	25.35%	-20.36%
NOPAT Q/Q Growth	1.43%	6.81%	1.16%	6.08%	8.61%	-3.86%	0.36%	0.82%	-3.29%	16.81%	-15.04%
Net Income Q/Q Growth	2.10%	5.93%	1.07%	6.47%	8.69%	-2.79%	0.90%	-0.96%	-1.63%	-69.62%	-701.60%
EPS Q/Q Growth	1.33%	4.65%	1.07%	6.47%	7.08%	-2.79%	0.90%	-0.96%	-2.17%	-100.00%	-500.00%
Operating Cash Flow Q/Q Growth	-9.09%	29.34%	-16.78%	14.79%	12.11%	-2.56%	5.86%	-4.32%	-2.27%	238.85%	-64.55%
Free Cash Flow Firm Q/Q Growth	-20.73%	35.71%	-339.24%	144.13%	8.37%	0.94%	-0.79%	-63.45%	-100.02%	1.76%	-563.02%
Invested Capital Q/Q Growth	3.17%	0.92%	11.91%	-0.66%	-0.12%	-0.80%	-0.64%	1.09%	1.85%	-1.18%	0.10%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.55%	49.35%	47.64%	47.15%	46.81%	46.34%	46.94%	45.91%	46.10%	49.36%	50.19%
EBITDA Margin	20.96%	22.03%	20.90%	22.43%	22.20%	20.70%	20.26%	20.21%	15.76%	15.07%	19.19%
Operating Margin	17.54%	18.76%	17.55%	18.13%	17.64%	16.44%	16.15%	15.83%	11.12%	4.56%	6.35%
EBIT Margin	17.25%	18.26%	17.11%	18.33%	17.91%	16.45%	15.86%	15.72%	11.18%	3.74%	5.71%
Profit (Net Income) Margin	11.33%	11.86%	11.37%	12.27%	15.89%	14.53%	14.22%	13.00%	9.16%	-2.78%	-1.02%
Tax Burden Percent	65.14%	64.48%	65.82%	65.95%	86.05%	82.48%	82.26%	80.89%	80.23%	103.76%	65.86%
Interest Burden Percent	100.81%	100.73%	100.98%	101.54%	103.07%	107.09%	109.04%	102.19%	102.15%	-71.67%	-27.13%
Effective Tax Rate	34.86%	35.53%	34.18%	34.05%	13.95%	17.52%	17.74%	19.11%	19.77%	0.00%	0.00%
Return on Invested Capital (ROIC)	13.90%	14.56%	13.87%	13.72%	17.83%	15.61%	14.78%	14.27%	9.74%	1.22%	1.07%
ROIC Less NNEP Spread (ROIC-NNEP)	14.20%	15.28%	14.39%	12.81%	16.24%	13.93%	13.49%	14.03%	9.41%	-35.17%	-6.25%
Return on Net Nonoperating Assets (RNNOA)	-3.97%	-4.34%	-4.19%	-3.68%	-5.58%	-5.56%	-6.05%	-6.49%	-4.15%	-2.36%	-1.37%
Return on Equity (ROE)	9.93%	10.22%	9.68%	10.04%	12.25%	10.05%	8.73%	7.78%	5.59%	-1.14%	-0.30%
Cash Return on Invested Capital (CROIC)	-13.96%	11.51%	-7.62%	3.55%	11.56%	9.81%	11.78%	-4.23%	0.00%	-151.58%	-1.21%
Operating Return on Assets (OROA)	13.43%	14.02%	13.06%	13.42%	12.43%	10.37%	8.88%	8.58%	6.16%	1.11%	1.16%
Return on Assets (ROA)	8.82%	9.11%	8.68%	8.99%	11.03%	9.16%	7.97%	7.09%	5.05%	-0.82%	-0.21%
Return on Common Equity (ROCE)	9.93%	10.22%	9.68%	10.04%	12.25%	10.05%	8.73%	7.78%	5.59%	-1.14%	-0.30%
Return on Equity Simple (ROE_SIMPLE)	9.15%	9.57%	9.04%	9.32%	11.28%	9.43%	8.20%	7.24%	5.44%	-0.73%	-0.30%
Net Operating Profit after Tax (NOPAT)	28	34	37	43	60	56	56	60	47	26	41
NOPAT Margin	11.42%	12.10%	11.55%	11.96%	15.18%	13.56%	13.28%	12.81%	8.92%	3.19%	4.44%
Net Nonoperating Expense Percent (NNEP)	-0.30%	-0.72%	-0.52%	0.91%	1.59%	1.68%	1.29%	0.25%	0.33%	36.40%	7.32%
Cost of Revenue to Revenue	50.45%	50.65%	52.36%	52.85%	53.19%	53.66%	53.06%	54.09%	53.90%	50.64%	49.81%
SG&A Expenses to Revenue	9.88%	8.91%	9.09%	9.55%	9.62%	9.85%	10.60%	10.93%	15.70%	24.46%	21.63%
R&D to Revenue	3.37%	3.38%	3.08%	2.90%	2.73%	3.09%	3.53%	3.47%	3.23%	3.17%	2.43%
Operating Expenses to Revenue	32.02%	30.58%	30.09%	29.02%	29.17%	29.90%	30.79%	30.07%	34.98%	44.80%	43.85%
Earnings before Interest and Taxes (EBIT)	43	52	55	66	71	68	66	74	59	31	53
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	52	62	67	80	88	86	85	95	83	124	177
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.52	4.93	4.58	5.12	6.97	4.60	5.20	5.88	3.22	1.21	0.91
Price to Tangible Book Value (P/TBV)	7.23	7.38	7.20	8.10	8.76	5.66	6.87	8.01	4.48	0.00	0.00
Price to Revenue (P/Rev)	5.60	6.12	5.77	6.73	9.81	7.09	9.01	10.54	5.41	4.60	3.08
Price to Earnings (P/E)	49.21	51.64	50.67	55.09	61.85	48.81	63.36	81.13	59.06	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.03%	1.94%	1.97%	1.82%	1.62%	2.05%	1.58%	1.23%	1.69%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	5.66	6.78	5.89	6.92	10.58	7.21	8.98	9.93	4.88	1.17	0.92
Enterprise Value to Revenue (EV/Rev)	5.30	5.72	5.43	6.33	9.28	6.45	8.19	9.73	4.69	5.38	3.86
Enterprise Value to EBITDA (EV/EBITDA)	25.28	25.97	25.98	28.24	41.83	31.13	40.43	48.14	29.76	35.67	20.10
Enterprise Value to EBIT (EV/EBIT)	30.71	31.32	31.74	34.56	51.84	39.18	51.64	61.89	41.94	143.78	67.63
Enterprise Value to NOPAT (EV/NOPAT)	46.38	47.28	47.01	52.97	61.17	47.53	61.66	75.98	52.56	168.37	86.84
Enterprise Value to Operating Cash Flow (EV/OCF)	60.50	36.98	49.38	37.65	53.44	41.81	39.88	56.22	36.33	107.77	101.12
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	59.79	0.00	204.86	94.35	75.64	77.35	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.28	0.28
Long-Term Debt to Equity	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.28	0.28
Financial Leverage	-0.28	-0.28	-0.29	-0.29	-0.34	-0.40	-0.45	-0.46	-0.44	0.07	0.22
Leverage Ratio	1.13	1.12	1.12	1.12	1.11	1.10	1.10	1.10	1.11	1.38	1.45
Compound Leverage Factor	1.14	1.13	1.13	1.13	1.15	1.17	1.19	1.12	1.13	-0.99	-0.39
Debt to Total Capital	0.61%	0.58%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	22.03%	22.03%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.61%	0.58%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	22.03%	22.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	-0.02%	0.00%	-0.01%	0.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.41%	99.42%	100.01%	99.97%	100.00%	100.00%	100.00%	100.00%	100.00%	77.97%	77.97%
Debt to EBITDA	0.04	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.14	5.01
Net Debt to EBITDA	-1.44	-1.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.16	4.04
Long-Term Debt to EBITDA	0.04	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.14	5.01
Debt to NOPAT	0.07	0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	33.72	21.63
Net Debt to NOPAT	-2.64	-3.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	24.37	17.47
Long-Term Debt to NOPAT	0.07	0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	33.72	21.63
Altman Z-Score	23.75	27.76	26.77	28.01	43.01	32.94	33.78	39.43	18.44	2.09	1.74
Noncontrolling Interest Sharing Ratio	0.00%	-0.01%	-0.01%	0.01%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	7.56	9.08	8.68	8.14	9.71	11.75	11.08	11.03	8.05	4.03	3.82
Quick Ratio	5.14	6.81	6.14	5.89	7.49	9.15	8.83	8.82	6.18	2.74	2.23
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-28	27	-20	11	39	35	44	-18	-0.00	-3,253	-46
Operating Cash Flow to CapEx	187.72%	455.27%	248.43%	413.46%	330.04%	435.45%	357.05%	303.57%	278.51%	63.19%	31.68%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-228.11	-0.01	-58.12	-0.63
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1,039.60	944.97	0.73	0.48
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	697.14	605.68	-0.43	-1.04
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.78	0.77	0.76	0.73	0.69	0.63	0.56	0.55	0.55	0.30	0.20
Accounts Receivable Turnover	5.46	5.10	5.07	5.26	5.39	5.12	5.00	5.31	5.51	6.50	5.67
Inventory Turnover	2.79	2.79	2.90	2.75	2.84	2.74	2.45	2.59	2.55	3.25	2.85
Fixed Asset Turnover	6.49	6.55	6.48	6.15	5.90	5.60	5.45	5.23	5.00	5.32	3.88
Accounts Payable Turnover	11.04	10.59	11.41	11.82	11.44	11.17	9.93	10.23	9.71	7.49	5.76
Days Sales Outstanding (DSO)	66.86	71.63	72.06	69.39	67.72	71.23	73.00	68.76	66.30	56.12	64.42
Days Inventory Outstanding (DIO)	130.86	130.81	125.82	132.54	128.60	133.01	148.91	140.98	143.24	112.23	128.09
Days Payable Outstanding (DPO)	33.06	34.48	32.00	30.88	31.90	32.69	36.78	35.69	37.58	48.76	63.33
Cash Conversion Cycle (CCC)	164.66	167.97	165.89	171.05	164.43	171.56	185.13	174.06	171.95	119.59	129.19
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	232	239	296	328	349	370	382	459	506	3,785	3,873
Invested Capital Turnover	1.22	1.20	1.20	1.15	1.17	1.15	1.11	1.11	1.09	0.38	0.24
Increase / (Decrease) in Invested Capital	57	7.17	58	32	21	21	11	78	47	3,279	87
Enterprise Value (EV)	1,311	1,619	1,745	2,269	3,695	2,669	3,425	4,559	2,472	4,422	3,566
Market Capitalization	1,386	1,731	1,853	2,413	3,905	2,937	3,768	4,940	2,853	3,782	2,848
Book Value per Share	$8.36	$9.48	$10.77	$12.37	$10.86	$12.24	$13.71	$15.70	$8.23	$14.50	$14.52
Tangible Book Value per Share	$5.23	$6.33	$6.85	$7.82	$8.64	$9.95	$10.36	$11.52	$5.91	($2.81)	($2.32)
Total Capital	308	353	404	472	560	638	725	840	887	4,020	4,033
Total Debt	1.88	2.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	885	888
Total Long-Term Debt	1.88	2.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	885	888
Net Debt	-75	-112	-108	-144	-211	-268	-344	-381	-381	640	717
Capital Expenditures (CapEx)	12	9.62	14	15	21	15	24	27	24	65	111
Debt-free, Cash-free Net Working Capital (DFCFNWC)	87	92	112	113	126	144	145	157	168	195	264
Debt-free Net Working Capital (DFNWC)	164	206	220	257	337	411	489	538	549	440	435
Net Working Capital (NWC)	164	206	220	257	337	411	489	538	549	440	435
Net Nonoperating Expense (NNE)	0.23	0.67	0.57	-1.14	-2.81	-4.01	-3.93	-0.89	-1.27	49	50
Net Nonoperating Obligations (NNO)	-75	-112	-108	-144	-211	-268	-344	-381	-381	651	728
Total Depreciation and Amortization (D&A)	9.18	11	12	15	17	18	18	21	24	93	125
Debt-free, Cash-free Net Working Capital to Revenue	35.28%	32.35%	34.81%	31.63%	31.74%	34.71%	34.73%	33.46%	31.85%	23.70%	28.56%
Debt-free Net Working Capital to Revenue	66.20%	72.68%	68.36%	71.72%	84.71%	99.30%	116.92%	114.81%	104.13%	53.55%	47.06%
Net Working Capital to Revenue	66.20%	72.68%	68.36%	71.72%	84.71%	99.30%	116.92%	114.81%	104.13%	53.55%	47.06%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.29	$0.34	$0.37	$0.43	$0.62	$0.58	$0.57	$0.57	$0.45	($0.12)	($0.04)
Adjusted Weighted Average Basic Shares Outstanding	97.96M	99.02M	100.20M	101.90M	103.51M	104.56M	105.10M	106.50M	107.68M	188.88M	216.48M
Adjusted Diluted Earnings per Share	$0.29	$0.34	$0.36	$0.43	$0.61	$0.58	$0.57	$0.57	$0.45	($0.12)	($0.04)
Adjusted Weighted Average Diluted Shares Outstanding	97.96M	99.02M	100.20M	101.90M	103.51M	104.56M	105.72M	107.12M	108.02M	188.88M	216.48M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	97.96M	99.02M	100.20M	101.90M	103.51M	104.56M	105.93M	107.48M	107.84M	216.31M	216.69M
Normalized Net Operating Profit after Tax (NOPAT)	28	34	37	43	60	56	56	60	47	26	41
Normalized NOPAT Margin	11.42%	12.10%	11.55%	11.96%	15.18%	13.56%	13.28%	12.81%	8.92%	3.19%	4.44%
Pre Tax Income Margin	17.39%	18.40%	17.28%	18.61%	18.46%	17.62%	17.29%	16.07%	11.42%	-2.68%	-1.55%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	944.28	818.61	0.55	0.72
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	769.14	653.22	0.47	0.56
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	601.82	479.32	-0.61	-0.80
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	426.68	313.93	-0.69	-0.96
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	5.21%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Neogen's official financial filings.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q2 2025	Q3 2025
Period end date	5/31/2022	8/31/2022	11/30/2022	2/28/2023	5/31/2023	8/31/2023	11/30/2023	2/29/2024	5/31/2024	11/30/2024	2/28/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.94%	3.15%	76.25%	70.19%	72.61%	73.02%	-0.18%	4.84%	-2.07%	0.71%	-3.42%
EBITDA Growth	-5.20%	-58.03%	-26.41%	239.04%	126.88%	319.68%	213.47%	-3.57%	-19.00%	-1,174.14%	-9.23%
EBIT Growth	-8.56%	-73.56%	-210.98%	130.05%	33.83%	222.13%	188.11%	-25.47%	-54.78%	-3,796.71%	-32.62%
NOPAT Growth	-10.00%	-72.25%	-151.32%	110.12%	19.64%	264.70%	288.94%	-23.34%	-46.50%	-3,262.70%	-54.96%
Net Income Growth	-5.08%	-69.50%	-486.41%	50.47%	-62.75%	-71.15%	91.67%	-124.69%	-197.18%	-12,985.23%	-441.89%
EPS Growth	-6.67%	-68.75%	-290.00%	-20.00%	-78.57%	-80.00%	89.47%	-125.00%	-166.67%	-10,400.00%	-400.00%
Operating Cash Flow Growth	-7.19%	-160.93%	-204.93%	-358.97%	346.13%	262.69%	183.92%	-76.96%	-70.60%	0.00%	164.10%
Free Cash Flow Firm Growth	47.09%	-40.08%	-4,065.32%	-8,749.35%	-9,853.24%	-4,392.45%	98.79%	99.10%	97.60%	263.78%	1,590.29%
Invested Capital Growth	10.24%	17.48%	691.19%	670.56%	647.59%	631.82%	1.32%	1.00%	2.31%	-10.09%	-11.43%
Revenue Q/Q Growth	9.24%	-5.53%	73.81%	-5.12%	10.79%	-5.30%	0.28%	-0.36%	3.49%	0.00%	-4.44%
EBITDA Q/Q Growth	95.10%	-53.74%	19.43%	214.50%	30.56%	-14.42%	-10.79%	-3.25%	9.66%	0.00%	108.18%
EBIT Q/Q Growth	190.46%	-69.05%	-347.79%	203.27%	68.97%	-25.50%	-32.23%	-12.65%	2.53%	0.00%	101.59%
NOPAT Q/Q Growth	172.94%	-66.75%	-213.02%	304.86%	55.41%	1.36%	-41.45%	-16.88%	8.46%	0.00%	101.18%
Net Income Q/Q Growth	174.83%	-65.18%	-903.24%	119.57%	-31.97%	-73.03%	-332.00%	42.01%	-167.80%	0.00%	97.60%
EPS Q/Q Growth	180.00%	-64.29%	-480.00%	121.05%	-25.00%	-66.67%	-300.00%	50.00%	-100.00%	0.00%	97.62%
Operating Cash Flow Q/Q Growth	209.36%	-169.36%	-32.40%	8.85%	632.93%	-74.71%	-31.71%	-292.22%	188.55%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	12.71%	-127.96%	-4,313.23%	-0.77%	1.82%	-2.89%	98.81%	24.79%	-161.41%	0.00%	584.37%
Invested Capital Q/Q Growth	1.85%	5.45%	605.68%	1.66%	-1.18%	3.23%	-2.29%	1.34%	0.10%	0.00%	-0.17%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.40%	47.05%	48.92%	49.47%	50.94%	50.99%	50.85%	51.08%	47.92%	49.01%	49.90%
EBITDA Margin	17.62%	8.63%	5.93%	19.65%	23.16%	20.93%	18.62%	18.08%	19.16%	-198.57%	16.99%
Operating Margin	12.87%	4.58%	-3.33%	7.19%	9.69%	8.36%	6.30%	5.25%	5.51%	-197.82%	2.45%
EBIT Margin	13.12%	4.30%	-6.13%	6.67%	10.17%	8.00%	5.41%	4.74%	4.70%	-198.57%	3.31%
Profit (Net Income) Margin	10.68%	3.94%	-18.19%	3.75%	2.30%	0.66%	-1.52%	-0.88%	-2.29%	-197.30%	-4.96%
Tax Burden Percent	79.11%	78.23%	122.73%	-362.39%	72.84%	90.38%	93.06%	34.73%	84.62%	95.74%	112.65%
Interest Burden Percent	102.86%	117.03%	241.80%	-15.52%	31.10%	9.07%	-30.16%	-53.65%	-57.52%	103.78%	-133.05%
Effective Tax Rate	20.89%	21.78%	0.00%	0.00%	27.16%	9.62%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	11.12%	3.85%	-0.69%	1.68%	2.70%	3.08%	1.05%	0.89%	0.93%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	10.93%	3.73%	-27.48%	-0.03%	-5.81%	-4.39%	-0.99%	-0.57%	-1.18%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-4.82%	-1.61%	-1.88%	0.00%	-0.39%	-0.46%	-0.21%	-0.13%	-0.26%	0.00%	0.00%
Return on Equity (ROE)	6.29%	2.24%	-2.58%	1.67%	2.31%	2.62%	0.84%	0.76%	0.67%	0.00%	0.00%
Cash Return on Invested Capital (CROIC)	0.00%	-9.06%	-154.36%	-153.01%	-151.58%	-150.85%	-0.29%	0.26%	-1.21%	0.00%	0.00%
Operating Return on Assets (OROA)	7.23%	2.39%	-1.40%	1.75%	3.02%	2.65%	1.07%	0.97%	0.95%	0.00%	0.00%
Return on Assets (ROA)	5.88%	2.19%	-4.15%	0.99%	0.68%	0.22%	-0.30%	-0.18%	-0.46%	0.00%	0.00%
Return on Common Equity (ROCE)	6.29%	2.24%	-2.58%	1.67%	2.31%	2.62%	0.84%	0.76%	0.67%	0.00%	0.00%
Return on Equity Simple (ROE_SIMPLE)	0.00%	4.12%	-0.52%	-0.43%	0.00%	-1.30%	-0.07%	0.05%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	14	4.74	-5.36	11	17	17	10	8.42	9.13	-320	3.79
NOPAT Margin	10.18%	3.58%	-2.33%	5.03%	7.06%	7.55%	4.41%	3.68%	3.85%	-138.48%	1.72%
Net Nonoperating Expense Percent (NNEP)	0.18%	0.12%	26.79%	1.71%	8.51%	7.48%	2.04%	1.46%	2.11%	18.98%	1.98%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	0.43%	0.25%	-	-	-8.99%	0.11%
Cost of Revenue to Revenue	53.60%	52.95%	51.08%	50.53%	49.06%	49.01%	49.15%	48.92%	52.08%	50.99%	50.10%
SG&A Expenses to Revenue	15.53%	21.11%	33.47%	21.27%	20.60%	19.70%	22.52%	22.76%	21.52%	24.98%	25.24%
R&D to Revenue	2.73%	3.69%	2.98%	3.33%	2.92%	2.94%	2.51%	2.12%	2.17%	2.21%	2.02%
Operating Expenses to Revenue	33.53%	42.47%	52.25%	42.28%	41.25%	42.63%	44.55%	45.83%	42.42%	246.83%	47.45%
Earnings before Interest and Taxes (EBIT)	18	5.69	-14	15	25	18	12	11	11	-459	7.31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	25	11	14	43	56	48	43	41	45	-459	38
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.22	2.55	0.57	1.22	1.21	1.60	1.17	1.18	0.91	1.15	0.82
Price to Tangible Book Value (P/TBV)	4.48	3.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	5.41	4.24	2.83	5.31	4.60	5.51	4.05	4.01	3.08	0.00	0.00
Price to Earnings (P/E)	59.06	61.84	0.00	0.00	0.00	0.00	0.00	2,376.75	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.69%	1.62%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.88	3.57	0.65	1.18	1.17	1.48	1.13	1.15	0.92	1.11	0.86
Enterprise Value to Revenue (EV/Rev)	4.69	3.59	3.86	6.28	5.38	6.36	4.78	4.78	3.86	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	29.76	28.51	39.92	48.85	35.67	39.74	24.99	23.62	20.10	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	41.94	44.21	149.26	184.45	143.78	213.09	80.79	67.08	67.63	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	52.56	54.98	152.40	201.28	168.37	244.51	110.79	91.89	86.84	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	36.33	62.10	0.00	0.00	107.77	73.80	38.45	44.64	101.12	202.59	43.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	444.31	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.30	0.28	0.28	0.28	0.28	0.28	0.28	0.33	0.33
Long-Term Debt to Equity	0.00	0.00	0.30	0.28	0.28	0.28	0.28	0.28	0.28	0.33	0.33
Financial Leverage	-0.44	-0.43	0.07	0.08	0.07	0.11	0.21	0.23	0.22	0.25	0.26
Leverage Ratio	1.11	1.10	1.39	1.37	1.38	1.36	1.47	1.45	1.45	1.49	1.48
Compound Leverage Factor	1.14	1.28	3.37	-0.21	0.43	0.12	-0.44	-0.78	-0.83	1.54	-1.97
Debt to Total Capital	0.00%	0.00%	22.93%	22.06%	22.03%	22.09%	22.03%	22.01%	22.03%	25.06%	25.08%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.06%	0.00%	0.00%	0.07%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	22.93%	22.06%	22.03%	22.09%	21.97%	22.01%	22.03%	24.99%	25.08%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	77.07%	77.94%	77.97%	77.91%	77.97%	77.99%	77.97%	74.94%	74.92%
Debt to EBITDA	0.00	0.00	15.16	9.55	7.14	6.12	5.13	4.72	5.01	0.00	0.00
Net Debt to EBITDA	0.00	0.00	10.63	7.57	5.16	5.29	3.81	3.82	4.04	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	15.16	9.55	7.14	6.12	5.12	4.72	5.01	0.00	0.00
Debt to NOPAT	0.00	0.00	57.87	39.35	33.72	37.68	22.76	18.37	21.63	0.00	0.00
Net Debt to NOPAT	0.00	0.00	40.56	31.20	24.37	32.57	16.87	14.88	17.47	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	57.87	39.35	33.72	37.68	22.69	18.37	21.63	0.00	0.00
Altman Z-Score	18.30	16.52	1.16	2.12	2.09	2.69	2.01	2.05	1.71	0.00	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	8.05	9.07	4.22	5.18	4.03	4.41	3.54	3.82	3.82	3.77	3.91
Quick Ratio	6.18	6.58	2.75	3.08	2.74	2.35	2.16	2.17	2.23	2.01	2.04
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-33	-75	-3,297	-3,322	-3,262	-3,356	-40	-30	-78	65	446
Operating Cash Flow to CapEx	162.63%	-108.83%	-162.83%	-113.23%	358.70%	75.22%	64.44%	-94.01%	110.49%	0.00%	59.68%
Free Cash Flow to Firm to Interest Expense	0.00	-37,353.50	-160.48	-190.29	-181.68	-181.85	-2.21	-1.64	-4.20	3.59	25.14
Operating Cash Flow to Interest Expense	0.00	-7,071.50	-0.91	-0.98	5.07	1.25	0.87	-1.65	1.44	0.00	1.09
Operating Cash Flow Less CapEx to Interest Expense	0.00	-13,569.50	-1.47	-1.84	3.65	-0.41	-0.48	-3.41	0.14	0.00	-0.74
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.55	0.56	0.23	0.26	0.30	0.33	0.20	0.20	0.20	0.00	0.00
Accounts Receivable Turnover	5.51	5.89	5.36	6.02	6.50	6.96	6.18	5.81	5.67	0.00	0.00
Inventory Turnover	2.55	2.47	2.74	2.90	3.25	2.80	3.06	2.79	2.85	0.00	0.00
Fixed Asset Turnover	5.00	4.82	5.07	5.35	5.32	4.30	4.62	4.25	3.88	0.00	0.00
Accounts Payable Turnover	9.71	11.57	5.88	8.88	7.49	10.36	4.74	6.07	5.76	0.00	0.00
Days Sales Outstanding (DSO)	66.30	61.98	68.06	60.61	56.12	52.46	59.02	62.84	64.42	0.00	0.00
Days Inventory Outstanding (DIO)	143.24	147.54	133.06	125.88	112.23	130.42	119.28	130.68	128.09	0.00	0.00
Days Payable Outstanding (DPO)	37.58	31.54	62.10	41.12	48.76	35.22	76.99	60.18	63.33	0.00	0.00
Cash Conversion Cycle (CCC)	171.95	177.97	139.02	145.37	119.59	147.67	101.31	133.34	129.19	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	506	534	3,768	3,830	3,785	3,907	3,818	3,869	3,873	3,432	3,427
Invested Capital Turnover	1.09	1.07	0.30	0.33	0.38	0.41	0.24	0.24	0.24	0.00	0.00
Increase / (Decrease) in Invested Capital	47	79	3,292	3,333	3,279	3,373	50	38	87	-385	-442
Enterprise Value (EV)	2,472	1,906	2,433	4,525	4,422	5,770	4,330	4,441	3,566	3,825	2,943
Market Capitalization	2,853	2,253	1,786	3,824	3,782	5,001	3,671	3,722	2,848	3,073	2,180
Book Value per Share	$8.23	$8.20	$28.81	$14.46	$14.50	$14.49	$14.55	$14.53	$14.52	$12.32	$12.26
Tangible Book Value per Share	$5.91	$6.76	($6.10)	($2.98)	($2.81)	($2.27)	($2.57)	($2.45)	($2.32)	($2.15)	($2.08)
Total Capital	887	884	4,030	4,010	4,020	4,024	4,037	4,034	4,033	3,562	3,551
Total Debt	0.00	0.00	924	885	885	889	889	888	888	892	891
Total Long-Term Debt	0.00	0.00	924	885	885	889	887	888	888	890	891
Net Debt	-381	-348	648	701	640	769	659	719	717	752	763
Capital Expenditures (CapEx)	13	13	12	15	25	31	24	32	24	0.00	32
Debt-free, Cash-free Net Working Capital (DFCFNWC)	168	193	214	265	195	297	220	276	264	282	283
Debt-free Net Working Capital (DFNWC)	549	541	491	448	440	418	450	445	435	422	411
Net Working Capital (NWC)	549	541	491	448	440	418	448	445	435	419	411
Net Nonoperating Expense (NNE)	-0.70	-0.47	36	2.79	11	16	14	10	15	136	15
Net Nonoperating Obligations (NNO)	-381	-350	662	705	651	772	670	723	728	763	766
Total Depreciation and Amortization (D&A)	6.30	5.73	28	28	31	30	30	31	34	0.00	30
Debt-free, Cash-free Net Working Capital to Revenue	31.85%	36.37%	34.00%	36.77%	23.70%	32.80%	24.27%	29.72%	28.56%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	104.13%	101.83%	77.81%	62.19%	53.55%	46.08%	49.67%	47.85%	47.06%	0.00%	0.00%
Net Working Capital to Revenue	104.13%	101.83%	77.81%	62.19%	53.55%	46.08%	49.39%	47.85%	47.06%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.14	$0.05	($0.19)	$0.04	$0.03	$0.01	($0.02)	($0.01)	($0.02)	($2.10)	($0.05)
Adjusted Weighted Average Basic Shares Outstanding	107.68M	107.84M	216.13M	216.22M	188.88M	216.31M	216.41M	216.60M	216.48M	216.81M	217.03M
Adjusted Diluted Earnings per Share	$0.14	$0.05	($0.19)	$0.04	$0.03	$0.01	($0.02)	($0.01)	($0.02)	($2.10)	($0.05)
Adjusted Weighted Average Diluted Shares Outstanding	108.02M	107.86M	216.13M	216.40M	188.88M	216.85M	216.41M	216.60M	216.48M	216.81M	217.03M
Adjusted Basic & Diluted Earnings per Share	$0.14	$0.00	$0.00	$0.00	$0.03	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	107.84M	107.84M	216.15M	216.22M	216.31M	216.70M	216.52M	216.61M	216.69M	216.94M	217.04M
Normalized Net Operating Profit after Tax (NOPAT)	14	4.74	-5.36	11	17	17	10	8.42	9.13	2.73	3.79
Normalized NOPAT Margin	10.18%	3.58%	-2.33%	5.03%	7.06%	7.55%	4.41%	3.68%	3.85%	1.18%	1.72%
Pre Tax Income Margin	13.50%	5.03%	-14.82%	-1.04%	3.16%	0.73%	-1.63%	-2.54%	-2.70%	-206.08%	-4.40%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	2,845.00	-0.69	0.83	1.37	0.99	0.69	0.59	0.60	-25.31	0.41
NOPAT to Interest Expense	0.00	2,371.00	-0.26	0.63	0.95	0.94	0.56	0.46	0.49	-17.65	0.21
EBIT Less CapEx to Interest Expense	0.00	-3,653.00	-1.25	-0.03	-0.04	-0.66	-0.66	-1.16	-0.70	0.00	-1.42
NOPAT Less CapEx to Interest Expense	0.00	-4,127.00	-0.82	-0.23	-0.46	-0.72	-0.79	-1.30	-0.81	0.00	-1.62
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Neogen's Financials

When does Neogen's financial year end?

According to the most recent income statement we have on file, Neogen's fiscal year ends in May. Their fiscal year 2024 ended on May 31, 2024.

How has Neogen's net income changed over the last 10 years?

Neogen's net income appears to be on a downward trend, with a most recent value of -$9.42 million in 2024, falling from $28.03 million in 2014. The previous period was -$22.87 million in 2023. Find out what analysts predict for Neogen in the coming months.

What is Neogen's operating income?

Neogen's total operating income in 2024 was $58.66 million, based on the following breakdown:

Total Gross Profit: $463.90 million
Total Operating Expenses: $405.24 million

How has Neogen revenue changed over the last 10 years?

Over the last 10 years, Neogen's total revenue changed from $247.41 million in 2014 to $924.22 million in 2024, a change of 273.6%.

How much debt does Neogen have?

Neogen's total liabilities were at $1.40 billion at the end of 2024, a 1.1% decrease from 2023, and a 3,501.7% increase since 2014.

How much cash does Neogen have?

In the past 10 years, Neogen's cash and equivalents has ranged from $40.68 million in 2014 to $170.61 million in 2024, and is currently $170.61 million as of their latest financial filing in 2024.

How has Neogen's book value per share changed over the last 10 years?

Over the last 10 years, Neogen's book value per share changed from 8.36 in 2014 to 14.52 in 2024, a change of 73.7%.

Related Companies

This page (NASDAQ:NEOG) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Neogen (NEOG) Financials

Frequently Asked Questions About Neogen's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Neogen (NEOG) Financials

Annual Income Statements for Neogen

Quarterly Income Statements for Neogen

Annual Cash Flow Statements for Neogen

Quarterly Cash Flow Statements for Neogen

Annual Balance Sheets for Neogen

Quarterly Balance Sheets for Neogen

Annual Metrics and Ratios for Neogen

Quarterly Metrics and Ratios for Neogen

Frequently Asked Questions About Neogen's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools